EN

Rankings / Health Care

Waters WAT

Analytical instruments. Waters Corporation, listed on NYSE.

Based on the FY2025 annual report (Jan 2025 – Dec 2025)

Waters' market cap is
about $44.50 billion.

#239 by market cap among 289 companies, based on the Nov 5, 2026 close. FY2025 revenue was $3.165286B.

Share price (close)
$453.08
Close on Nov 5, 2026 · per share
P/E ratio
42.1x
Closing price ÷ latest annual EPS
Market cap
$44.50B
#239 of 289
Revenue
$3.165286B
#287 of 299 · +7.0% YoY
Operating income
$802.588M
#202 of 231 · −2.9% YoY
Net income
$642.629M
#267 of 298 · +0.8% YoY
Free cash flow
$539.81M
#231 of 261 · −12.9% YoY
Total assets
$5.07655B
#291 of 299 · +11.5% YoY
Dividends paid
—
Not reported
Dividend per share
—
Not reported
Dividend yield
—
No dividend, or a different currency
Shares outstanding
59,549,000 shares
As of Dec 31, 2025

Where the revenue went

Revenue is set at 100% and split into what went to costs, R&D, operating expenses and taxes, and what was left as profit.

  • Cost of revenue40.7%
  • R&D6.2%
  • SG&A and other27.7%
  • Taxes, interest & other5.1%
  • Net income20.3%

Profitability and stability

Each figure comes with its rank among 300 companies. The further right the dot, the higher the rank.

Revenue growthHow much revenue grew from the previous fiscal year
+7.0%
#171 of 299
Revenue is growing steadily. The median across 299 companies is +7.9%.
Operating marginShare of revenue kept as profit from the core business
25.4%
#74 of 231
25.4% of revenue was kept as operating profit. The median across 231 companies is 19.2%.
Net marginShare of revenue left as profit after interest and taxes
20.3%
#92 of 298
After taxes, 20.3% of revenue was left as net income. The median across 298 companies is 14.0%.
FCF marginShare of revenue left as cash after capital spending
17.1%
#120 of 261
Cash is left over after capital spending. The median across 261 companies is 15.8%.
ROEHow much profit the company earned on shareholders' equity in a year
29.3%
#83 of 276
Earns a lot relative to its equity. The median across 276 companies is 16.8%.
Debt-to-equityLiabilities relative to equity. Lower means less debt
98.2%
#71 of 244
Liabilities are smaller than equity. The median across 244 companies is 159.6%.

Revenue and profit over time

Gray bars show revenue and the green part inside shows net income. The number above each bar is revenue (abbreviated) and the number below is net margin. Hover over a bar to see the exact amounts.

FY2021 Revenue $2.785874B / Net income $692.843M2.79B24.9%FY2021FY2022 Revenue $2.971956B / Net income $707.755M2.97B23.8%FY2022FY2023 Revenue $2.956416B / Net income $642.234M2.96B21.7%FY2023FY2024 Revenue $2.958387B / Net income $637.834M2.96B21.6%FY2024FY2025 Revenue $3.165286B / Net income $642.629M3.17B20.3%FY2025
Currency: US dollars. Years are the years in which each fiscal year ended.

Where the cash went

Unlike profit, cash flow is money that actually came in and went out.

  • Cash from operations$652.555M
  • Capital spending−$112.745M
  • Free cash flow (FCF)$539.81M

Whose money funds the assets

The company's assets, split into borrowed money (liabilities) and shareholders' money (equity).

  • Total assets$5.07655B
  • Total liabilities$2.515308B
  • Total equity$2.561242B
  • Cash and equivalents$587.831M

Compared with similar companies

Based on each company's latest annual report, so fiscal year ends may differ.

Compare in detail
CompanyAnnual revenueNet incomeRevenue growthOperating marginNet margin
WatersWAT$3.165286B$642.629M+7.0%25.4%20.3%
IQVIAIQV$16.31B$1.36B+5.9%13.4%8.3%
Agilent TechnologiesA$6.948B$1.303B+6.7%21.3%18.8%
Mettler-ToledoMTD$4.026399B$869.193M+4.0%—21.6%
DanaherDHR$24.568B$3.614B+2.9%19.1%14.7%

What the company does

Waters makes analytical instruments such as liquid chromatography systems and mass spectrometers.

The fiscal year ends around December each year.

Related companies: IQVIA, Agilent Technologies, Mettler-Toledo, Danaher

Financial statements

Last 5 fiscal years. Currency: US dollars.

Show the table
ItemFY2021FY2022FY2023FY2024FY2025
Revenue2.785874B2.971956B2.956416B2.958387B3.165286B
Cost of revenue———1.200201B1.288822B
Gross profit———1.758186B1.876464B
R&D expense168.358M176.19M174.945M183.027M195.711M
Operating income821.707M873.395M817.676M826.353M802.588M
Pretax income806.193M837.846M736.243M754.868M754.878M
Net income692.843M707.755M642.234M637.834M642.629M
EPS (diluted)$11.17$11.73$10.84$10.71$10.76
Operating cash flow747.274M611.661M602.809M762.123M652.555M
Capital expenditures——160.632M142.481M112.745M
Free cash flow (FCF)——442.177M619.642M539.81M
Total assets3.094932B3.281453B4.626854B4.553795B5.07655B
Total liabilities2.727378B2.776965B3.476513B2.725288B2.515308B
Total equity367.554M504.488M1.150341B1.828507B2.561242B
Cash and equivalents501.234M480.529M395.076M325.355M587.831M
Original filing10-K10-K10-K10-K10-K

Source: SEC EDGAR filings for Waters Corporation · CIK 0001000697 · US-GAAP